Cancer Advisor

By Editorial Team | Medically reviewed and updated | Last updated: July 2026 | Consolidates and supersedes the six-part Warburg Effect series (June 2026) and "The Warburg Effect Revisited in 2026" (May 2026) Quick Answer The Warburg Effect is the century-old observation that many cancer cells generate energy through aerobic glycolysis — converting glucose to lactate even when oxygen is abundant — rather than relying primarily on mitochondrial oxidative phosphorylation. It is not caused by broken mitochondria, as Otto Warburg originally believed; it is driven by oncogene signaling (KRAS, MYC, HIF-1α, PI3K-AKT-mTOR) that rewires metabolism to supply the building blocks of rapid growth. The strongest Warburg phenotype tends to appear in the most aggressive cancers — pancreatic cancer, glioblastoma, small-cell lung cancer, and triple-negative breast cancer among them — and underlies the entire field of FDG-PET imaging. As of 2026, dozens of drugs and nutraceuticals a...

Abstract Background Pancreatic cancer remains one of the most lethal malignancies despite modern chemotherapy. Increasing public interest has emerged around repurposed antiparasitic drugs such as fenbendazole, mebendazole, and ivermectin. Objective To reorganise and analyse anecdotal pancreatic cancer case reports involving fenbendazole and ivermectin-based protocols in order to identify recurring response patterns and clinically relevant subgroups. Methods Publicly available anecdotal reports were reviewed qualitatively and reorganised according to biomarker response, metastatic pattern, chemotherapy use, histology, and adjunct metabolic therapies. Results Recurring themes included rapid CA19-9 decline, apparent liver metastasis responses, heavy reliance on combination chemotherapy, delayed-response patterns, and extensive use of nutraceutical adjuncts. Most reported responders received multi-modal therapy rather than antiparasitic monotherapy. Conclusion The reports are highly vulner...